SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-007404
Filing Date
2019-05-15
Accepted
2019-05-15 16:16:24
Documents
79
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 789239
2 ex31-1.htm EX-31.1 9005
3 ex32-1.htm EX-32.1 4688
  Complete submission text file 0001493152-19-007404.txt   4207409

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE xtnt-20190331.xml EX-101.INS 602432
5 XBRL SCHEMA FILE xtnt-20190331.xsd EX-101.SCH 53828
6 XBRL CALCULATION FILE xtnt-20190331_cal.xml EX-101.CAL 74580
7 XBRL DEFINITION FILE xtnt-20190331_def.xml EX-101.DEF 198686
8 XBRL LABEL FILE xtnt-20190331_lab.xml EX-101.LAB 378254
9 XBRL PRESENTATION FILE xtnt-20190331_pre.xml EX-101.PRE 316449
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 19828385
SIC: 2836 Biological Products, (No Diagnostic Substances)